- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2162-3619
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia ; volume:11 ; number:1 ; day:16 ; month:11 ; year:2022 ; pages:1-15 ; date:12.2022
Experimental hematology & oncology ; 11, Heft 1 (16.11.2022), 1-15, 12.2022
- Creator
-
Zhou, Weijun
Yu, Jinyi
Li, Yilu
Wang, Kankan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-022-00353-3
- URN
-
urn:nbn:de:101:1-2023012909135631638459
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhou, Weijun
- Yu, Jinyi
- Li, Yilu
- Wang, Kankan
- SpringerLink (Online service)
Other Objects (12)
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Natural killer cell-based immunotherapy for acute myeloid leukemia
Neoantigen vaccine: an emerging tumor immunotherapy
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
TCR-like antibodies in cancer immunotherapy
High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells
CD8+ T cell-based cancer immunotherapy
TCR diversity – a universal cancer immunotherapy biomarker?
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy
Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency
TCR engineered T cells for solid tumor immunotherapy
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Natural killer cell-based immunotherapy for acute myeloid leukemia
Neoantigen vaccine: an emerging tumor immunotherapy
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
TCR-like antibodies in cancer immunotherapy
High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells
CD8+ T cell-based cancer immunotherapy
TCR diversity – a universal cancer immunotherapy biomarker?
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy
Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency
TCR engineered T cells for solid tumor immunotherapy
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Natural killer cell-based immunotherapy for acute myeloid leukemia
Neoantigen vaccine: an emerging tumor immunotherapy
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
TCR-like antibodies in cancer immunotherapy
High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells
CD8+ T cell-based cancer immunotherapy
TCR diversity – a universal cancer immunotherapy biomarker?
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy
Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency